Quantcast

Latest Amgen Stories

2015-02-25 16:27:07

Third Phase 3 Study Met Non-Inferiority and Superiority Endpoints in the Reduction of Parathyroid Hormone THOUSAND OAKS, Calif., Feb.

2015-02-25 16:26:47

THOUSAND OAKS, Calif., Feb. 25, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Cowen and Company 35(th )Annual Health Care Conference at 2:50 p.m.

2015-02-17 16:26:30

Company currently has two biosimilar applications (filgrastim [Neupogen(®)]) and pegfilgrastim [Neulasta(®)]) under active review by FDA. TORONTO, Feb.

2015-02-11 16:27:30

RnRMarketResearch.com adds "Fatigue - Pipeline Review, H1 2015" to its store. This provides an overview of the Fatigue's therapeutic pipeline. DALLAS, Feb.

2015-02-03 16:25:53

RnRMarketResearch.com adds "Peritoneal Cancer - Pipeline Review, H1 2015" to its store. This provides an overview of the Peritoneal Cancer's therapeutic pipeline. DALLAS, Feb.

2015-02-01 20:21:14

RnRMarketResearch.com adds "Asthma - Pipeline Review, H1 2015" to its store. The report provides an overview of the Asthma's therapeutic pipeline. DALLAS, Feb.


Word of the Day
cespitose
  • Growing in low tufty patches.
The word 'cespitose' comes from a Latin word meaning 'turf'.
Related